Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Ibrexafungerp (SCY-078), a new class of unique glucan synthase inhibitors (triterpene compounds) (Rivero-Menendez et al., 2021)
The Takeaway In addition to the reminder that its a great time to be a GLP-1 biotech, Roches acquisition of Carmot Therapeutics is another sign that were still in the early innings of the GLP-1 ballgame
What the broader data shows When researchers look beyond individual pancreatitis cases and analyze data from large clinical trials, the picture is reassuring
No Increased Risk of Hypoglycaemic Episodes During 48 H of Subcutaneous Glucagon-Like-Peptide-1 Administration in Fasting Healthy Subjects
US$ 28.11
US$ 29.49
US$ 25.21
US$ 28.18
